We are live on ! Find out more
CNSY

Cerenome, Inc. Common Stock

22 hedge funds and large institutions have $872K invested in Cerenome, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

10% more funds holding

Funds holding: 2022 (+2)

0.02% less ownership

Funds ownership: 0.04%0.02% (-0.02%)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

45% less capital invested

Capital invested by funds: $1.58M → $872K (-$707K)

Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
5
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
OCA
26
Otter Creek Advisors
Florida
-$147K -880 Closed
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
-$21K -123 Closed
Citadel Advisors
28
Citadel Advisors
Florida
-$7K -45 Closed

CNSY Hedge Fund Activity: Q4 2022 in Review

22 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Cerenome, Inc. Common Stock (CNSY) for Q4 2022, worth a combined $872K — down 45% from $1.58M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CNSY positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $80.9K. The largest seller was Parkman Healthcare Partners, cutting an estimated $315K.

  • 22 institutional investors held Cerenome, Inc. Common Stock (CNSY) as of Q4 2022, up from 20 in Q3 2022.
  • Funds reported $872K of Cerenome, Inc. Common Stock stock for Q4 2022, down 45% quarter-over-quarter.
  • 5 funds opened new Cerenome, Inc. Common Stock positions in Q4 2022 and 3 closed out, a net change of +2 holders.
  • The largest Cerenome, Inc. Common Stock buyer in Q4 2022 was Schonfeld Strategic Advisors, an estimated $80.9K added.
  • The largest Cerenome, Inc. Common Stock seller in Q4 2022 was Parkman Healthcare Partners, an estimated $315K sold.

Based on aggregated 13F filings for Q4 2022.